Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for October 1, 2014

October 1, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

UCLA spinout NeuroSigma seeks $50m in IPO

October 1, 2014 by Alexander Soule

NeuroSigma is aiming to net as much as $50.2 million in its upcoming IPO, as the UCLA spinout develops a noninvasive system to treat epilepsy that proves resistant to drug regimens.

UCLA spinout NeuroSigma seeks $50m in IPO

NeuroSigma aims to reap as much as $50.2 million in its upcoming initial public offering for the UCLA spinout's noninvasive system to treat drug-resistant epilepsy.

LoneStar Heart wins CE Mark for hydrogel heart implant

October 1, 2014 by Alexander Soule

LoneStar Heart wins CE Mark approval in the European Union for its Algisyl-LVR hydrogel implant, a hydrogel implant designed to treat heart failure.

LoneStar Heart wins CE Mark for hydrogel heart implant

Laguna Hills, Calif.-based LoneStar Heart said it won CE Mark approval in the European Union for its Algisyl-LVR hydrogel implant for the treatment of advanced heart failure. 

Medtronic, Covidien name peripherals biz transition team

October 1, 2014 by Alexander Soule

Medtronic and Covidien appoint representatives to the integration team charged with combining their peripheral vascular businesses as part of their $43 billion merger.

Covidien, Medtronic name peripherals biz transition team

Our first dive into the new Open Payments system

October 1, 2014 by MassDevice

The government's data on payments to doctors and hospitals by drug and device makers is incomplete and hard to penetrate – but here's a first look.

Our first dive into the new Open Payments system

David Sleight/ProPublica

by Charles Ornstein, ProPublica

The federal government unveiled data Tuesday detailing 4.4 million payments made to doctors and teaching hospitals by pharmaceutical and medical device companies.

FDA launches cybersecurity initiative

October 1, 2014 by Alexander Soule

The FDA asks medical device manufacturers to submit documentation about controls they have in place to mitigate the threat of hackers accessing their devices, including ongoing software patches and updates to operating systems.

FDA launches cybersecurity initiative

The FDA is asking medical device manufacturers to submit documentation about cybersecurity controls they have in place to mitigate the threat of hackers accessing devices, including ongoing software patches and updates to operating systems.

New inversion rules are unlikely to scuttle Medtronic's pending $43B merger with Covidien | The week in medtech M&A

October 1, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy; New U.S. tax rules may lead Medtronic to redo inversion deal; Ackman threatens to sue Allergan again over potential Salix deal; Tengion is on the auction block

New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy

September 24, 2014 by Brad Perriello

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp